Origin Materials, Inc. (ORGN)
NASDAQ:ORGN
ORGN Stock Chart & Stats
$0.46
-$0.06(-4.88%)
At close: 4:00 PM EST
$0.46
-$0.06(-4.88%)
Day’s Range― - ―
52-Week Range$1.90 - $28.50
Previous CloseN/A
Volume571.43K
Average Volume (3M)130.08K
Market Cap
$10.58M
Enterprise Value$5.36M
Total Cash (Recent Filing)$53.47M
Total Debt (Recent Filing)$27.71M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
May 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-38.61
Shares Outstanding5,425,037
10 Day Avg. Volume164,684
30 Day Avg. Volume130,082
Financial Highlights & Ratios
PEG Ratio-19.73
Price to Book (P/B)9.01K
Price to Sales (P/S)49603.67
P/FCF Ratio-14.90K
Enterprise Value/Market Cap0.51
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit-0.50
Enterprise Value/Ebitda-0.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-9.3
Revenue Forecast (FY)$112.00M
Bulls Say, Bears Say
Bulls Say
Contracts And ExpansionORGN secures $100mn contract for PET caps, expanding its production capabilities in the US and Europe.
Financial PerformanceOrigin's PET-based caps and closures have potential, with plans to produce millions of caps and generate positive EBITDA.
Bears Say
Leadership ChangesThe departure of co-CEO Rich Riley, who led the CMF commercialization effort, adds to the uncertainty.
Technology UncertaintyThe future of Origin's cellulose-based technology is uncertain, leading to a lower stock rating.
Origin Materials News
ORGN FAQ
What was Origin Materials, Inc.’s price range in the past 12 months?
Origin Materials, Inc. lowest stock price was $1.90 and its highest was $28.50 in the past 12 months.
What is Origin Materials, Inc.’s market cap?
Origin Materials, Inc.’s market cap is $10.58M.
When is Origin Materials, Inc.’s upcoming earnings report date?
Origin Materials, Inc.’s upcoming earnings report date is May 12, 2026 which is in 29 days.
How were Origin Materials, Inc.’s earnings last quarter?
Origin Materials, Inc. released its earnings results on Mar 27, 2026. The company reported -$38.61 earnings per share for the quarter, missing the consensus estimate of N/A by -$38.61.
Is Origin Materials, Inc. overvalued?
According to Wall Street analysts Origin Materials, Inc.’s price is currently Overvalued.
Does Origin Materials, Inc. pay dividends?
Origin Materials, Inc. pays a Semiannually dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Origin Materials, Inc. dividends here
What is Origin Materials, Inc.’s EPS estimate?
Origin Materials, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Materials, Inc. have?
Origin Materials, Inc. has 5,425,037 shares outstanding.
What happened to Origin Materials, Inc.’s price movement after its last earnings report?
Origin Materials, Inc. reported an EPS of -$38.61 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -34.153%.
Which hedge fund is a major shareholder of Origin Materials, Inc.?
Currently, no hedge funds are holding shares in ORGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Origin Materials, Inc.
Micromidas, Inc., doing business as Origin Materials, produces and commercializes plant-based PET plastic. It develops a platform for turning the carbon found in biomass into useful materials, while capturing carbon in the process. The company serves tire filler, carbon black, agriculture, and activated carbon markets. Micromidas, Inc. has a strategic alliance with Palantir Technologies Inc. The company was incorporated in 2008 and is based in West Sacramento, California with a facility in Sarnia, Canada.
ORGN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Negative
The call conveyed meaningful technical and commercial progress — a validated new PET cap design, an initial retail placement, distribution partnerships, and full procurement of production lines — but these positives are overshadowed by significant financial and execution risks: a $165.9M impairment tied to ceasing the furanics platform, constrained liquidity with cash runway into Q3 2026 absent financing, limited access to existing facilities due to low stock price, and a one-year delay to adjusted EBITDA breakeven (2027 to 2028). While product prospects and partner interest remain, near-term survival and slower-than-expected commercialization elevate downside risk.View all ORGN earnings summariesTechnical Analysis
Ownership Overview
4.65% Insiders
4.19% Mutual Funds
2.50% Other Institutional Investors
85.64% Public Companies and
Individual Investors